EP2588106A4 - Verzögert freigesetzte pharmazeutische zusammensetzung mit pramipexol oder einem pharmazeutisch zulässigen salz davon mit erhöhter stabilität - Google Patents

Verzögert freigesetzte pharmazeutische zusammensetzung mit pramipexol oder einem pharmazeutisch zulässigen salz davon mit erhöhter stabilität

Info

Publication number
EP2588106A4
EP2588106A4 EP11801051.1A EP11801051A EP2588106A4 EP 2588106 A4 EP2588106 A4 EP 2588106A4 EP 11801051 A EP11801051 A EP 11801051A EP 2588106 A4 EP2588106 A4 EP 2588106A4
Authority
EP
European Patent Office
Prior art keywords
sustained
pharmaceutically acceptable
pharmaceutical composition
acceptable salt
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11801051.1A
Other languages
English (en)
French (fr)
Other versions
EP2588106A2 (de
Inventor
Sang-Joon Lee
Kwan-Young Chang
Jae-Soon Ahn
Jae-Min Cho
Sung-Hoon Kam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyundai Pharm Co Ltd
Original Assignee
Hyundai Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyundai Pharm Co Ltd filed Critical Hyundai Pharm Co Ltd
Publication of EP2588106A2 publication Critical patent/EP2588106A2/de
Publication of EP2588106A4 publication Critical patent/EP2588106A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP11801051.1A 2010-07-02 2011-05-12 Verzögert freigesetzte pharmazeutische zusammensetzung mit pramipexol oder einem pharmazeutisch zulässigen salz davon mit erhöhter stabilität Withdrawn EP2588106A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100064044A KR101307334B1 (ko) 2010-07-02 2010-07-02 프라미펙솔 또는 이의 약학적으로 허용되는 염을 포함하는 안정성이 개선된 서방형 약학 조성물
PCT/KR2011/003515 WO2012002644A2 (en) 2010-07-02 2011-05-12 Sustained-release pharmaceutical composition containing pramipexole or pharmaceutically acceptable salt thereof with improved stability

Publications (2)

Publication Number Publication Date
EP2588106A2 EP2588106A2 (de) 2013-05-08
EP2588106A4 true EP2588106A4 (de) 2014-01-01

Family

ID=45402507

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11801051.1A Withdrawn EP2588106A4 (de) 2010-07-02 2011-05-12 Verzögert freigesetzte pharmazeutische zusammensetzung mit pramipexol oder einem pharmazeutisch zulässigen salz davon mit erhöhter stabilität

Country Status (4)

Country Link
EP (1) EP2588106A4 (de)
JP (1) JP2013530212A (de)
KR (1) KR101307334B1 (de)
WO (1) WO2012002644A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2112920B1 (de) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Protonenpumpeninhibitoren enthaltende kapseln, die verschieden aufgebaute untereinheiten zur verzögerten wirkstofffreisetzung enthalten
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CA2648280C (en) 2006-04-03 2014-03-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP2906202A4 (de) * 2012-10-15 2016-04-27 Isa Odidi Orale wirkstofffreisetzungsformulierungen
CN105456216B (zh) * 2014-08-18 2019-11-05 江苏神龙药业股份有限公司 盐酸普拉克索缓释片剂组合物及其制备方法
CN106474084B (zh) * 2015-08-28 2020-12-11 江苏先声药业有限公司 一种盐酸普拉克索缓释制剂及其制备方法
CN107951853B (zh) * 2016-10-17 2022-04-08 海思科制药(眉山)有限公司 一种盐酸普拉克索缓释药物组合物及其制备方法
CN108785263B (zh) * 2017-04-26 2021-06-29 江苏恒瑞医药股份有限公司 普拉克索或其药用盐的固体药物组合物及其制备方法
CN109966256B (zh) * 2017-12-28 2022-08-02 北京北大维信生物科技有限公司 一种普拉克索缓释药物组合物、其制备方法及用途

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0428038A2 (de) * 1989-11-09 1991-05-22 Boehringer Ingelheim Kg Transdermale Applikation von 2-Amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
WO2007002518A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Delayed release or extended-delayed release dosage forms of pramipexole
WO2007054976A2 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd. Lipid based controlled release pharmaceutical composition
WO2009152041A2 (en) * 2008-06-09 2009-12-17 Supernus Pharmaceuticals, Inc. Controlled release formulations of pramipexole
WO2011037976A2 (en) * 2009-09-22 2011-03-31 Dr. Reddy's Laboratories Limited Pramipexole pharmaceutical formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005538105A (ja) * 2002-07-25 2005-12-15 ファルマシア・コーポレーション 水不溶性ポリマーおよび水溶性の小孔形成物質からなる２層により被覆された固体剤形の製造方法
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
KR20070050081A (ko) * 2004-08-13 2007-05-14 베링거 인겔하임 인터내셔날 게엠베하 프라미펙솔 또는 약제학적으로 허용되는 이의 염을포함하는 연장 방출형 펠렛 제형, 이의 제조방법 및 이의용도
WO2006046256A1 (en) 2004-10-27 2006-05-04 Alembic Limited Extended release formulation of pramipexole dihydrochloride
WO2007090882A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Pharmaceutical extended release compositions comprising pramipexole
WO2008068778A2 (en) 2006-12-05 2008-06-12 Alembic Limited Extended release pharmaceutical composition of pramipexole

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0428038A2 (de) * 1989-11-09 1991-05-22 Boehringer Ingelheim Kg Transdermale Applikation von 2-Amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
WO2007002518A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Delayed release or extended-delayed release dosage forms of pramipexole
WO2007054976A2 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd. Lipid based controlled release pharmaceutical composition
WO2009152041A2 (en) * 2008-06-09 2009-12-17 Supernus Pharmaceuticals, Inc. Controlled release formulations of pramipexole
WO2011037976A2 (en) * 2009-09-22 2011-03-31 Dr. Reddy's Laboratories Limited Pramipexole pharmaceutical formulations

Also Published As

Publication number Publication date
EP2588106A2 (de) 2013-05-08
JP2013530212A (ja) 2013-07-25
KR20120003278A (ko) 2012-01-10
KR101307334B1 (ko) 2013-09-12
WO2012002644A3 (en) 2012-04-12
WO2012002644A2 (en) 2012-01-05

Similar Documents

Publication Publication Date Title
IL259921B (en) A new stabilizing factor for pharmaceutical proteins
EP2588106A4 (de) Verzögert freigesetzte pharmazeutische zusammensetzung mit pramipexol oder einem pharmazeutisch zulässigen salz davon mit erhöhter stabilität
HUP1000069A2 (en) New salts for the preparation of pharmaceutical composition
HRP20181170T1 (hr) Novi derivat cefalosporina i njegov farmaceutski pripravak
IL225238A0 (en) pharmaceutical preparation
IL225457A0 (en) Pharmaceutical composition
LT2619182T (lt) Farmacinė kompozicija
HK1181389A1 (en) Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof
PT2579858E (pt) Composição farmacêutica que contém ivabradina
GB201010453D0 (en) Pharmaceutical composition
ZA201207375B (en) Stabilized pharmaceutical composition
HRP20160901T1 (hr) Farmaceutski pripravak koji sadrži solifenacin
IL230907A0 (en) Salt and formations of a pyrazolopyrimidine compound, a medical composition that includes the above, and a preparation and use process for them
EP2386301A4 (de) Pharmazeutische zusammensetzung aus levoamlopidin oder pharmazeutisch akzeptablen salzen daraus und beta-blockern sowie verwendung davon
GB201001911D0 (en) Pharmaceutical composition
IL238071B (en) Pharmaceutical composition of 1-adamantylethyloxy-3-morpholino-2-propanol or pharmaceutically acceptable salts thereof for the treatment of cardiovascular disease
EP2543373A4 (de) Pharmazeutische verbundzusammensetzung aus levoamlodipin
EP2628488A4 (de) Pharmazeutische zusammensetzung mit verzögerter freisetzung
IL223324A0 (en) Novel pharmaceutical compounds
HU1000006D0 (en) Improved pharmaceutical composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130114

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20131204

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/38 20060101ALI20131128BHEP

Ipc: A61K 9/20 20060101ALI20131128BHEP

Ipc: A61K 9/22 20060101ALI20131128BHEP

Ipc: A61K 31/425 20060101AFI20131128BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140701